Next Article in Journal
Global Perspectives on Mycotoxin Reference Materials (Part I): Insights from Multi-Supplier Comparison Study Including Aflatoxin B1, Deoxynivalenol and Zearalenone
Next Article in Special Issue
Isolation and Pharmacological Characterisation of Pre-Synaptic Neurotoxins from Thai and Javanese Russell’s Viper (Daboia siamensis) Venoms
Previous Article in Journal
Assessing the Use of BotulinumtoxinA for Hyperactive Urinary Tract Dysfunction a Decade after Approval: A Single-Blind Study to Evaluate the Reduction in Pain in OnabotulinumtoxinA Detrusor Injection Using Different Injection Needles
Previous Article in Special Issue
Effect of Seaweed-Derived Fucoidans from Undaria pinnatifida and Fucus vesiculosus on Coagulant, Proteolytic, and Phospholipase A2 Activities of Snake Bothrops jararaca, B. jararacussu, and B. neuwiedi Venom
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Tiny but Mighty: Vipera ammodytes meridionalis (Eastern Long-Nosed Viper) Ontogenetic Venom Variations in Procoagulant Potency and the Impact on Antivenom Efficacies

1
Adaptive Biotoxicology Lab, School of the Environment, University of Queensland, St. Lucia, QLD 4072, Australia
2
Alphabiotoxine Laboratory Sprl, Barberie 15, 7911 Montroeul-au-Bois, Belgium
3
Inosan Biopharma, 28108 Alcobendas, Madrid, Spain
4
MicroPharm Limited, Newcastle Emlyn SA38 9BY, UK
*
Author to whom correspondence should be addressed.
Toxins 2024, 16(9), 396; https://doi.org/10.3390/toxins16090396
Submission received: 12 August 2024 / Revised: 1 September 2024 / Accepted: 12 September 2024 / Published: 14 September 2024
(This article belongs to the Special Issue Snake Venom: Toxicology and Associated Countermeasures)

Abstract

The Eastern Long-Nosed Viper (Vipera ammodytes meridionalis) is considered one of the most venomous snakes in Europe. However, it is unknown whether ontogenetic variation in venom effects occurs in this subspecies and how this may impact antivenom efficacy. In this study, we compared the procoagulant activities of V. a. meridionalis venom on human plasma between neonate and adult venom phenotypes. We also examined the efficacy of three antivenoms—Viperfav, ViperaTAb, and Inoserp Europe—across our neonate and adult venom samples. While both neonate and adult V. a. meridionalis venoms produced procoagulant effects, the effects produced by neonate venom were more potent. Consistent with this, neonate venom was a stronger activator of blood-clotting zymogens, converting them into their active forms, with a rank order of Factor X >> Factor VII > Factor XII. Conversely, the less potent adult venom had a rank order of FXII marginally more activated than Factor VII, and both much more so than Factor X. This adds to the growing body of evidence that activation of factors besides FII (prothrombin) and FX are significant variables in reptile venom-induced coagulopathy. Although all three examined antivenoms displayed effective neutralization of both neonate and adult V. a. meridionalis venoms, they generally showed higher efficacy on adult venom than on neonate venom. The ranking of antivenom efficacy against neonate venom, from the most effective to the least effective, were Viperfav, Inoserp Europe, ViperaTAb; for adult venom, the ranking was Inoserp Europe, Viperfav, ViperaTAb. Our data reveal ontogenetic variation in V. a meridionalis, but this difference may not be of clinical concern as antivenom was effective at neutralizing both adult and neonate venom phenotypes. Regardless, our results highlight a previously undocumented ontogenetic shift, likely driven by the documented difference in prey preference observed for this species across age classes
Keywords: Echis; coagulopathy; antivenom; small-molecule enzyme inhibitor; factor activation Echis; coagulopathy; antivenom; small-molecule enzyme inhibitor; factor activation

Share and Cite

MDPI and ACS Style

Qiao, Z.; Jones, L.; Bourke, L.A.; Seneci, L.; Chowdhury, A.; Violette, A.; Fourmy, R.; Soria, R.; Aldridge, M.; Fry, B.G. Tiny but Mighty: Vipera ammodytes meridionalis (Eastern Long-Nosed Viper) Ontogenetic Venom Variations in Procoagulant Potency and the Impact on Antivenom Efficacies. Toxins 2024, 16, 396. https://doi.org/10.3390/toxins16090396

AMA Style

Qiao Z, Jones L, Bourke LA, Seneci L, Chowdhury A, Violette A, Fourmy R, Soria R, Aldridge M, Fry BG. Tiny but Mighty: Vipera ammodytes meridionalis (Eastern Long-Nosed Viper) Ontogenetic Venom Variations in Procoagulant Potency and the Impact on Antivenom Efficacies. Toxins. 2024; 16(9):396. https://doi.org/10.3390/toxins16090396

Chicago/Turabian Style

Qiao, Zichen, Lee Jones, Lachlan A. Bourke, Lorenzo Seneci, Abhinandan Chowdhury, Aude Violette, Rudy Fourmy, Raul Soria, Matt Aldridge, and Bryan G. Fry. 2024. "Tiny but Mighty: Vipera ammodytes meridionalis (Eastern Long-Nosed Viper) Ontogenetic Venom Variations in Procoagulant Potency and the Impact on Antivenom Efficacies" Toxins 16, no. 9: 396. https://doi.org/10.3390/toxins16090396

APA Style

Qiao, Z., Jones, L., Bourke, L. A., Seneci, L., Chowdhury, A., Violette, A., Fourmy, R., Soria, R., Aldridge, M., & Fry, B. G. (2024). Tiny but Mighty: Vipera ammodytes meridionalis (Eastern Long-Nosed Viper) Ontogenetic Venom Variations in Procoagulant Potency and the Impact on Antivenom Efficacies. Toxins, 16(9), 396. https://doi.org/10.3390/toxins16090396

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop